|
KMID : 1148920170510030217
|
|
Nuclear Medicine and Molecular Imaging
2017 Volume.51 No. 3 p.217 ~ p.226
|
|
|
Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer
|
|
Cho Ihn-Ho
Kong Eun-Jung
|
|
|
Abstract
|
|
|
|
The whole-body positron emission tomography (PET)/magnetic resonance (MR) scan is a cutting edge technology providing comprehensive structural information from MR imaging and functional features from PET in a single session. Recent research findings and clinical experience have shown that 18F-fluorodeoxyglucose (FDG) whole-body PET/MR imaging has a diagnostic performance comparable with or superior to that of PET/CT in the field of oncology, including for breast cancer. In particular, FDG PET/MR mammography in the prone position with the breast hanging in a pendant manner can provide more comprehensive information about the metabolism, anatomy, and functional features of a breast lesion than a whole-body PET/MR scan. This article reports on current state-of-the-art PET/MR mammography in patients with breast cancer and the prospects for potential application in the future.
|
|
|
KEYWORD
|
|
|
PET/MR, FDG, Breast cancer, Staging, Lymphatic metastasis, Attenuation correction
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|